Wells Fargo’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51 Hold
102
﹤0.01% 6597
2025
Q4
$60 Hold
102
﹤0.01% 6493
2025
Q3
$193 Hold
102
﹤0.01% 6350
2025
Q2
$91 Hold
102
﹤0.01% 6490
2025
Q1
$53 Hold
102
﹤0.01% 6445
2024
Q4
$52 Sell
102
-1,000
-91% -$1.52K ﹤0.01% 6498
2024
Q3
$3.9K Sell
1,102
-6,000
-84% -$38.2K ﹤0.01% 5962
2024
Q2
$56.2K Buy
7,102
+4,967
+233% +$45K ﹤0.01% 5251
2024
Q1
$28.9K Sell
2,135
-2,500
-54% -$29.7K ﹤0.01% 5464
2023
Q4
$50.1K Sell
4,635
-5,498
-54% -$62.1K ﹤0.01% 5279
2023
Q3
$65.9K Sell
10,133
-1,198
-11% -$14.7K ﹤0.01% 5030
2023
Q2
$204K Buy
11,331
+11,199
+8,484% +$261K ﹤0.01% 4574
2023
Q1
$3.09K Buy
132
+1
+0.8% +$25 ﹤0.01% 6161
2022
Q4
$3.28K Sell
131
-288
-69% -$9.58K ﹤0.01% 5886
2022
Q3
$13K Buy
419
+3
+0.7% +$118 ﹤0.01% 5582
2022
Q2
$16K Buy
416
+2
+0.5% +$76 ﹤0.01% 5559
2022
Q1
$17K Hold
414
﹤0.01% 6080
2021
Q4
$21K Buy
414
+20
+5% +$1.07K ﹤0.01% 6321
2021
Q3
$26K Buy
394
+333
+546% +$14.4K ﹤0.01% 5875
2021
Q2
$3K Sell
61
-314
-84% -$13.5K ﹤0.01% 6469
2021
Q1
$20K Sell
375
-5,835
-94% -$391K ﹤0.01% 6158
2020
Q4
$422K Sell
6,210
-1,261
-17% -$58.4K ﹤0.01% 4637
2020
Q3
$286K Sell
7,471
-3,852
-34% -$153K ﹤0.01% 4751
2020
Q2
$437K Buy
11,323
+1,493
+15% +$57.3K ﹤0.01% 4419
2020
Q1
$295K Buy
9,830
+2,395
+32% +$145K ﹤0.01% 4426
2019
Q4
$843K Buy
7,435
+3,003
+68% +$174K ﹤0.01% 3974
2019
Q3
$141K Buy
4,432
+2,367
+115% +$85.5K ﹤0.01% 5154
2019
Q2
$88K Buy
2,065
+1,545
+297% +$74.2K ﹤0.01% 5358
2019
Q1
$28K Buy
520
+100
+24% +$5.39K ﹤0.01% 5445
2018
Q4
$12K Sell
420
-4
-0.9% -$157 ﹤0.01% 5896
2018
Q3
$19K Buy
424
+400
+1,667% +$8.6K ﹤0.01% 5841
2018
Q2
$0 Sell
24
-1,647
-99% -$47.6K ﹤0.01% 6488
2018
Q1
$64K Buy
1,671
+116
+7% +$6.13K ﹤0.01% 5482
2017
Q4
$90K Buy
1,555
+1,481
+2,001% +$95.2K ﹤0.01% 5358
2017
Q3
$5K Buy
+74
New +$4.94K ﹤0.01% 6026

Other funds holding MTNB